Streamline Health Solutions (NASDAQ: STRM) reported Q1 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.91 million.

"Our first quarter performance was very solid as we began to realize the benefits of focusing our selling efforts on solutions in the middle of the revenue cycle to help our clients capture the financial reimbursement they deserve for the patient care they provided. Bookings in the quarter improved significantly to $3.4 million as we sold Abstracting, Clinical Documentation Integrity and eValuator solutions to current and new clients," stated David Sides, President and Chief Executive Officer, Streamline Health. "Our continued focus on tighter cost controls delivered improved bottom line results as well. Total operating expenses decreased by approximately 15 percent as compared to first quarter a year ago reducing operating loss in the quarter to approximately $363,000, down from last year's first quarter operating loss of $1,874,000. And net loss for the first quarter was approximately $569,000, a marked improvement over a $2 million loss in the first quarter of last year."

\"We remain committed to leading an industry movement to improve hospitals\' financial performance by moving mid-cycle billing interventions upstream - to improve coding accuracy before billing, enabling our clients to reduce lost revenue, mitigate overbill risk, and reduce denials and days in accounts receivable."

Highlights for the first quarter ended April 30, 2018 included:

• Revenues for the first quarter of 2018 were $6.3 million;
• Adjusted EBITDA for the first quarter of 2018 was $0.6 million;
• Net loss for the first quarter of 2018 was $569,000;
• New sales bookings for the first quarter of 2018 were $3.4 million; and
• Backlog at the end of the first quarter was $26.1 million.

For earnings history and earnings-related data on Streamline Health Solutions (STRM) click here.